These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37275318)

  • 1. Long-Term Outcomes of Randomized Controlled Trials Comparing Percutaneous Left Atrial Appendage Closure to Oral Anticoagulation for Nonvalvular Atrial Fibrillation: A Meta-Analysis.
    Madhavan MV; Howard JP; Brener MI; Der Nigoghossian C; Chen S; Makkar R; Osmancik P; Reddy VY; Holmes DR; Stone GW; Leon MB; Ahmad Y
    Struct Heart; 2023 Jan; 7(1):100096. PubMed ID: 37275318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
    Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
    Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies.
    Franchin L; Piroli F; Demola P; Mantovani F; Iannaccone M; Manfredi R; D'Ascenzo F; Fortuni F; Ugo F; Meucci F; Navazio A; Boccuzzi G
    Front Cardiovasc Med; 2023; 10():1212161. PubMed ID: 37829693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
    Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
    J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
    Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    D'Ancona G; Arslan F; Safak E; Weber D; Al Ammareen R; Ince H
    Int J Cardiol; 2022 Mar; 351():61-64. PubMed ID: 34929249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
    Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
    Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation.
    Saw J; Bennell MC; Singh SM; Wijeysundera HC
    Can J Cardiol; 2016 Nov; 32(11):1355.e9-1355.e14. PubMed ID: 27432692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
    Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.
    Panikker S; Lord J; Jarman JW; Armstrong S; Jones DG; Haldar S; Butcher C; Khan H; Mantziari L; Nicol E; Hussain W; Clague JR; Foran JP; Markides V; Wong T
    Eur Heart J; 2016 Dec; 37(46):3470-3482. PubMed ID: 26935273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current State of Left Atrial Appendage Closure.
    Kosturakis R; Price MJ
    Curr Cardiol Rep; 2018 Apr; 20(6):42. PubMed ID: 29680999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.